For its second fiscal quarter (ending June 30), Laboratory Corp of America Holdi (NYSE: LH) has reported E.P.S. of $2.44 compared to $1.75 a year ago. E.P.S. were $5.30 for the latest four quarters through June 30 versus $7.59 for the same period a year ago.
Recent Price Action
On 8/1/24, Laboratory Corp of America Holdi (NYSE: LH) stock enjoyed a very large increase of 8.3%, closing at $233.39. Moreover, trading volume in this advance was exceptionally high at 257% of normal. Relative to the market the stock has been weak over the last nine months but has risen 11.4% during the last week.
Current PriceTarget Research Rating
LH is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Laboratory has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Laboratory has a slightly negative Power Rating of 39 and a slightly negative Appreciation Score of 32, and the Negative Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment